Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Johnson and Johnson
Baxter
Cerilliant
Colorcon
Chinese Patent Office
Fuji
Healthtrust
Moodys

Generated: June 20, 2018

DrugPatentWatch Database Preview

DETROL Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Detrol, and what generic alternatives are available?

Detrol is a drug marketed by Pharmacia And Upjohn and is included in two NDAs. There are three patents protecting this drug and two Paragraph IV challenges.

The generic ingredient in DETROL is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.
Drug patent expirations by year for DETROL
Pharmacology for DETROL
Medical Subject Heading (MeSH) Categories for DETROL
Synonyms for DETROL
(+)-(r)-2-(a-[2-(diisopropylamino)ethyl]benzyl)-p-cresol tartrate
(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol
(+)-(R)-2-(I-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol L-tartrate (1:1) (salt)
(+)-(R)-2-[A-[2-(DIISOPROPYLAMINO) ETHYL]BENZYL]-P-CRESOL TARTRATE
(+)-(R)-3-(2-hydroxy-5-methylphenyl)-N,N-diisopropyl-3-phenylpropylamine
(+)-r)-2-{a-(2-(diisopropylamino)ethyl)benzyl}-p-cresol tartrate
(+)-Tolterodine
(2R,3R)-2,3-dihydroxybutanedioic acid; 2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol
(2R,3R)-2,3-dihydroxybutanedioic acid;2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol
(R)-(+)-N,N-Diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropylamine
(R)-(+)-Tolterodine
(R)-2-(3-(Bis(1-methylethyl)amino)-1-phenylpropyl)-4-methylphenol (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt)
(r)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-methylphenol
(R)-2-(3-(Diisopropylamino)-1-phenylpropyl)-4-methylphenol (2R,3R)-2,3-dihydroxysuccinate
(R)-2-(3-(Diisopropylamino)-1-phenylpropyl)-4-methylphenol 2,3-dihydroxysuccinate
(R)-2-(3-DIISOPROPYLAMINO-1-PHENYL-PROPYL)-4-METHYL-PHENOL L-TARTRATE
(R)-2-(3-Diisopropylamino-1-phenyl-propyl)-p-cresol L-tartrate
(R)-2-[3-(diisopropylamino)-1-phenylpropyl]-4-methylphenol
(R)-2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol L-Tartrate
(R)-2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenolL-Tartrate
(R)-2,3-BIS(1-METHYLETHYL)AMINO-1-PHENYLPROPYL-4-METHYLPHENOL
(R)-Tolterodine
(tolterodine tartrate)
124937-51-5
124937-52-6
124937-53-7
2-[(1R)-3-(di(propan-2-yl)amino)-1-phenylpropyl]-4-methylphenol
2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-methylphenol
2-[(1R)-3-[BIS(1-METHYLETHYL)AMINO]-1-PHENYLPROPYL]-4-METHYL-PHENOL TARTRATE
2-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol
2-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol (2R,3R)-2,3-dihydroxybutanedioate
2-[(1R)-3-[bis(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol
2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol
2-[3-[Bis(1-Methylethyl)Amino]-1-Phenylpropyl]-4-Methyl Phenol Monohydrobromide
2-{(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl}-4-methylphenol
209747-05-7
215929-30-9
27817-EP2269989A1
27817-EP2298767A1
27817-EP2314587A1
5T619TQR3R
937T515
937T526
AB00698547_13
AB00698547-12
AB14347
AB2000647
AB42195
AC-2617
AC-3472
AC1L9FDO
AC1L9FDR
ACM209747057
ACT03352
ACT04387
AJ-24600
AK-72840
AKOS015841711
AKOS015895578
AKOS015920262
AKOS015961803
Ambap124937-51-5
ANW-44905
API0004447
API0008372
AX8017869
BCP0726000292
BDBM50165008
BIDD:GT0318
BR-72840
C07750
C22H31NO.C4H6O6
C26H37NO7
CAS-124937-51-5
CCG-100865
CCG-221263
CHEBI:9622
CHEMBL1382
CHEMBL1722209
CPD000469196
CS-0441
CS-1799
CTK8B4394
D00646
D01148
D0BZ7W
DB01036
Detrol (TN)
Detrol LA
DETROL LA TARTRATE
Detrol LA;Kabi-2234;PNU-200583E
Detrusitol
Detrusitol (TN)
DETRUSITOL L-TARTRATE
Detrusitol SR
DS-1398
DSSTox_CID_3687
DSSTox_GSID_23687
DSSTox_RID_77147
DTXSID3023687
FT-0082150
FT-0082998
FT-0085110
FT-0602571
FT-0631119
FT-0675276
GTPL360
HMS2051E12
HMS2230E24
HMS2230P06
HY-90010
HY-A0024
J-005184
J-500064
Jsp001637
Jsp001638
Kabi 2234
Kabi-2234
KABI-2234 (TARTRATE)
KS-0000099P
KS-1121
KS-5165
L-tartaric acid; tolterodine
LS-172609
LS-187278
MFCD07771985
MLS001195620
MLS001304745
MLS001401389
MLS003915640
MLS006010051
MolPort-002-885-868
MolPort-003-850-574
MolPort-005-935-051
NC00115
NCGC00159519-02
NCGC00263557-01
OOGJQPCLVADCPB-HXUWFJFHSA-N
PHA-686464B
Phenol, 2-((1R)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-methyl-
Phenol, 2-((1R)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-methyl-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt)
Phenol, 2-(3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-methyl-, (R)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt)
Phenol,2-((1R)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-methyl-,(2R,3R)-2,3-dihydroxybutanedioate
PNU 200583
PNU 200583E
PNU-200583E
PNU-200583E (TARTRATE)
PNU-200583E L-TARTRATE
PubChem20792
Q-200223
RL01153
RT-015598
RTR-003803
S-(-)-Tolterodine
s-tolterodine
s2550
SAM001246691
SC-18999
SCHEMBL3064
SCHEMBL36881
SCHEMBL467372
SMR000469196
SMR000596518
SMR002544692
ST2402599
tolterodin
TOLTERODIN HYDROGEN TARTRATE
Tolterodina
tolterodine
Tolterodine (USAN/INN)
Tolterodine [USAN:INN:BAN]
tolterodine extended release capsules
TOLTERODINE HYDROBROMIC ACID SALT
Tolterodine L-Tartrate
tolterodine l-tartrate 124937-51-5
Tolterodine L-tartrate, >=98% (HPLC)
Tolterodine tartrate
Tolterodine tartrate (Detrol LA)
Tolterodine tartrate (JAN/USAN)
Tolterodine tartrate [USAN]
Tolterodine Tartrate|124937-52-6|Kabi-2234|PNU-200583E
tolterodine, tartrate
Tolterodinetartrate
Tolterodinhydrogentartrate
Tolterodinum
Tolterondine Tartrate
Tox21_111737
Tox21_111737_1
TWHNMSJGYKMTRB-KXYUELECSA-N
TWHNMSJGYKMTRB-VEIFNGETSA-N
Unidet
UNII-5T619TQR3R
UNII-WHE7A56U7K
Urotrol
WHE7A56U7K
ZINC968336

US Patents and Regulatory Information for DETROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-001 Mar 25, 1998 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for DETROL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-002 Mar 25, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-001 Mar 25, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-002 Mar 25, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-002 Mar 25, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for DETROL
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Tablets 1 mg and 2 mg ➤ Subscribe 0000-00-00
➤ Subscribe Extended-release Capsules 2 mg and 4 mg ➤ Subscribe 2007-07-30

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Colorcon
Queensland Health
Healthtrust
US Department of Justice
QuintilesIMS
Farmers Insurance
Moodys
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.